Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas Groot Koerkamp

Showing results (101-110 of 486) with videos related to

Pageof 49
Sort By:
Diagnostics (Basel, Switzerland)|August 26, 2022
FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic PerformancesSophie E M Veldhuijzen van Zanten, Kay J Pieterman, Bas P L Wijnhoven, et al.
Annals of Surgical Oncology|September 30, 2025
ASO Visual Abstract: Operative and Oncological Outcomes of Vascular Resection and Reconstruction for Perihilar CholangiocarcinomaEdoardo Poletto, Pim B Olthof, Frederik J H Hoogwater, et al.
Journal of the American College of Surgeons|February 18, 2018
Quantitative Imaging Features and Postoperative Hepatic Insufficiency: A Multi-Institutional Expanded CohortLinda M Pak, Jayasree Chakraborty, Mithat Gonen, et al.
Journal of Oncology|July 18, 2022
Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort StudyFleur van der Sijde, Jacob L van Dam, Bas Groot Koerkamp, et al.
Annals of Surgery|August 11, 2015
Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?Eran Sadot, Bas Groot Koerkamp, Julie N Leal, et al.
Cancer Medicine|September 7, 2018
Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population-based studyLydia G M van der Geest, Casper H J van Eijck, Bas Groot Koerkamp, et al.
The Journal of Pathology|July 28, 2022
Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitisEline Jca Kamp, Winand Nm Dinjens, Michail Doukas, et al.
Clinical and Translational Gastroenterology|October 5, 2021
Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor HeterogeneityEline J C A Kamp, Maikel P Peppelenbosch, Michail Doukas, et al.
Annals of Surgical Oncology|September 13, 2025
Operative and Oncological Outcomes of Vascular Resection and Reconstruction for Perihilar CholangiocarcinomaEdoardo Poletto, Pim B Olthof, Frederik J H Hoogwater, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 7, 2024
Lymphadenectomy for perihilar cholangiocarcinoma: therapeutic benefit of lymph node number and stationJun Kawashima, Abdullah Altaf, Yutaka Endo, et al.
Pageof 49

Showing results (101-110 of 486) with videos related to

Sort By:
Pageof 49
Diagnostics (Basel, Switzerland)|August 26, 2022
FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic PerformancesSophie E M Veldhuijzen van Zanten, Kay J Pieterman, Bas P L Wijnhoven, et al.
Annals of Surgical Oncology|September 30, 2025
ASO Visual Abstract: Operative and Oncological Outcomes of Vascular Resection and Reconstruction for Perihilar CholangiocarcinomaEdoardo Poletto, Pim B Olthof, Frederik J H Hoogwater, et al.
Journal of the American College of Surgeons|February 18, 2018
Quantitative Imaging Features and Postoperative Hepatic Insufficiency: A Multi-Institutional Expanded CohortLinda M Pak, Jayasree Chakraborty, Mithat Gonen, et al.
Journal of Oncology|July 18, 2022
Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort StudyFleur van der Sijde, Jacob L van Dam, Bas Groot Koerkamp, et al.
Annals of Surgery|August 11, 2015
Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?Eran Sadot, Bas Groot Koerkamp, Julie N Leal, et al.
Cancer Medicine|September 7, 2018
Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population-based studyLydia G M van der Geest, Casper H J van Eijck, Bas Groot Koerkamp, et al.
The Journal of Pathology|July 28, 2022
Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitisEline Jca Kamp, Winand Nm Dinjens, Michail Doukas, et al.
Clinical and Translational Gastroenterology|October 5, 2021
Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor HeterogeneityEline J C A Kamp, Maikel P Peppelenbosch, Michail Doukas, et al.
Annals of Surgical Oncology|September 13, 2025
Operative and Oncological Outcomes of Vascular Resection and Reconstruction for Perihilar CholangiocarcinomaEdoardo Poletto, Pim B Olthof, Frederik J H Hoogwater, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 7, 2024
Lymphadenectomy for perihilar cholangiocarcinoma: therapeutic benefit of lymph node number and stationJun Kawashima, Abdullah Altaf, Yutaka Endo, et al.
Pageof 49